Late effects of myeloablative stem cell transplantation or late effects of sickle cell disease itself

被引：8
|
作者：
Bernaudin, Francoise
Kuentz, Mathieu
Socie, Gerard
机构：
来源：
BLOOD | 2008年 / 111卷 / 03期
关键词：
D O I：
10.1182/blood-2007-11-121475
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1744 / 1744
页数：1
相关论文
共 50 条
  • [41] Cognitive late effects following allogeneic stem cell transplantation in haematological cancer patients
    Hutchinson, Amanda D.
    Thompson, Elise
    Loft, Nicole
    Lewis, Ian
    Wilson, Carlene
    Yong, Agnes S. M.
    EUROPEAN JOURNAL OF CANCER CARE, 2021, 30 (05)
  • [42] Late effects in children after allogenic stem cell transplantation (Allo-SCT)
    Llamas Poyato, M. J.
    Molina Hurtado, J. R.
    Chic Acevedo, C.
    Garcia Torres, E.
    Rodriguez Garcia, G.
    Martin Calvo, C.
    Rodriguez Villa, A.
    Rojas Contreras, R.
    Martinez Guibelarde, F.
    Herrera Arroyo, C.
    Gomez Garcia, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S256 - S257
  • [43] How I treat late effects in adults after allogeneic stem cell transplantation
    Savani, Bipin N.
    Griffith, Michelle L.
    Jagasia, Shubhada
    Lee, Stephanie J.
    BLOOD, 2011, 117 (11) : 3002 - 3009
  • [44] Characterizing the cutaneous late effects of allogeneic hematopoietic stem cell transplantation: A systematic review
    Bourkas, Adrienn N.
    Sibbald, Cathryn
    Chan, An-Wen
    Schechter, Tal
    Ali, Muhammad
    Pullattayil, Abdul Kareem
    Levy, Rebecca
    PEDIATRIC TRANSPLANTATION, 2024, 28 (01)
  • [45] Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases
    de Kloet, L. C.
    Bense, J. E.
    van der Stoep, M. Y. E. C.
    Louwerens, M.
    von Asmuth, E. G. J.
    Lankester, A. C.
    de Pagter, A. P. J.
    Hannema, S. E.
    BONE MARROW TRANSPLANTATION, 2022, 57 (10) : 1564 - 1572
  • [46] Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases
    L. C. de Kloet
    J. E. Bense
    M. Y. E. C. van der Stoep
    M. Louwerens
    E. G. J. von Asmuth
    A. C. Lankester
    A. P. J. de Pagter
    S. E. Hannema
    Bone Marrow Transplantation, 2022, 57 : 1564 - 1572
  • [47] Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study
    Hwang, Jessica P.
    Roundtree, Aimee K.
    Giralt, Sergio A.
    Suarez-Almazor, Maria
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2012, 2 (04) : 344 - 350
  • [48] Mobility and Muscle Strength in Recipients of Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from Sickle Transplant Evaluation of Longterm and Late Effects Registry (STELLaR)
    Veludhandi, Anirudh
    John, Tami D.
    Bakshi, Nitya
    Arnold, Staci D.
    Bhatia, Monica
    Lane, Peter A.
    Meacham, Lillian
    Khemani, Kirshma
    Chaudhury, Sonali
    Olowoselu, Festus Olusola
    Kasow, Kimberly A.
    Hsieh, Matthew
    Abraham, Allistair
    Guilcher, Gregory M. T.
    Krishnamurti, Lakshmanan
    BLOOD, 2021, 138
  • [49] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
    Volker Wiebking
    Sebastian Hütker
    Irene Schmid
    Stefanie Immler
    Tobias Feuchtinger
    Michael H. Albert
    Annals of Hematology, 2017, 96 : 1373 - 1377
  • [50] Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease
    Wiebking, Volker
    Hutker, Sebastian
    Schmid, Irene
    Immler, Stefanie
    Feuchtinger, Tobias
    Albert, Michael H.
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1373 - 1377
12345